Business
Tango Therapeutics to Participate in Upcoming Investor Conferences
BOSTON--(BUSINESS WIRE)-- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next
About this update from Tango Therapeutics, Inc.
[{"type":"text","content":" BOSTON--(BUSINESS WIRE)--\nTango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in the following upcoming investor conferences in September.\n\n\n2024 Wells Fargo Healthcare Conference\nDate: Wednesday, September 4, 2024\nTime: 12:45 PM ET\nLocation: Boston, MA\n\n\n2024 Cantor Global Healthcare Conference\nDate: Tuesday, September 17, 2024\nTime: 9:10 AM ET\nLocation: New York, NY\n\n\nA live webcast of the presentations will be available under the \"Events & Presentations\" tab on the “Investors” page on the Company's website on the day of the event. A replay of the webcasts will be archived on the Company's website for 90 days following the presentation.\n\n\nAbout Tango Therapeutics\n\n\nTango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing. For more information, please visit www.tangotx.com.\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20240828717768/en/\n\nInvestor Contact:\nSam Martin/Andrew Vulis\nArgot Partners\[email protected]\n\n\nMedia Contact:\nAmanda Brown Galgay\nSVP, Corporate Communications, Tango Therapeutics\[email protected]\n\n\nSource: Tango Therapeutics, Inc.","length":3661,"tagName":"div"}]